Outcomes
tumor
TUMOR
The primary endpoint was the pathologic complete response (pCR) rate. pCR was defined as no invasive tumor in the breast and lymph nodes (ypT0ypN0) and followed international guidelines [Additionally, biological samples were collected during the study to conduct molecular and clinical analyses to assess the presence of prognostic and predictive markers of benefit or resistance to the study regimens.